- Home
- IKNA vs MAXN Comparison
IKNA vs MAXN Comparison
Compare IKNA & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- MAXN
- Stock Information
- Founded
- IKNA 2016
- MAXN 2019
- Country
- IKNA United States
- MAXN Singapore
- Employees
- IKNA N/A
- MAXN N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- MAXN Semiconductors
- Sector
- IKNA Health Care
- MAXN Technology
- Exchange
- IKNA Nasdaq
- MAXN Nasdaq
- Market Cap
- IKNA 61.8M
- MAXN 61.7M
- IPO Year
- IKNA 2021
- MAXN N/A
- Fundamental
- Price
- IKNA $1.11
- MAXN $2.86
- Analyst Decision
- IKNA Buy
- MAXN Sell
- Analyst Count
- IKNA 2
- MAXN 6
- Target Price
- IKNA $3.00
- MAXN $195.80
- AVG Volume (30 Days)
- IKNA 84.2K
- MAXN 170.3K
- Earning Date
- IKNA 05-12-2025
- MAXN 05-29-2025
- Dividend Yield
- IKNA N/A
- MAXN N/A
- EPS Growth
- IKNA N/A
- MAXN N/A
- EPS
- IKNA N/A
- MAXN N/A
- Revenue
- IKNA N/A
- MAXN $689,010,000.00
- Revenue This Year
- IKNA N/A
- MAXN N/A
- Revenue Next Year
- IKNA N/A
- MAXN $34.68
- P/E Ratio
- IKNA N/A
- MAXN N/A
- Revenue Growth
- IKNA N/A
- MAXN N/A
- 52 Week Low
- IKNA $0.97
- MAXN $2.49
- 52 Week High
- IKNA $1.94
- MAXN $410.00
- Technical
- Relative Strength Index (RSI)
- IKNA 38.47
- MAXN 40.90
- Support Level
- IKNA $1.06
- MAXN $2.68
- Resistance Level
- IKNA $1.25
- MAXN $3.35
- Average True Range (ATR)
- IKNA 0.10
- MAXN 0.33
- MACD
- IKNA 0.00
- MAXN 0.05
- Stochastic Oscillator
- IKNA 39.83
- MAXN 43.07
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.